Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Alcohol Drinking 4Substance-Related Disorders 1Social Isolation 1Smoking Cessation 1Risk-Taking 1Pancreatic Cyst 1Head and Neck Neoplasms 1Driving Under the Influence 1Depression 1Carney Complex 1Binge-Eating Disorder 1Binge Drinking 1

Interventions

pembrolizumab 27Cisplatin 18Cetuximab 12Carboplatin 12Surveys and Questionnaires 8Radiotherapy 8Paclitaxel 8Docetaxel 6Radiotherapy, Intensity-Modulated 5Surgical Procedures, Operative 4dostarlimab 3Therapeutics 3Standard of Care 3Fluorouracil 3Cyclophosphamide 3Chemoradiotherapy 3Blood Specimen Collection 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3toripalimab 2nimotuzumab 2fludarabine 2durvalumab 2atezolizumab 2abemaciclib 2X-Rays 2Taxes 2Radiosurgery 2Radiation 2Nivolumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Head and Neck Neoplasms × Ethanol × 90 days × Clear all
NCT05570851 2026-04-17

Alcohol Cessation Among Head and Neck Cancer Survivors

Northwell Health

Phase NA Completed
126 enrolled
Head & Neck

Alcohol Drinking, Depression, Head and Neck Neoplasms, Social Isolation, Substance-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡